Ýïîïðîñòåíîë (Epoprostenol)
Ýïîïðîñòåíîë (Epoprostenol) Ýïîïðîñòåíîë (Epoprostenol)
 ëîãèí:   
 ïàðîëü:  Ðåãèñòðàöèÿ 

ÌÅÍÞ
   Ïîëíàÿ ïîïóëÿðíàÿ áèáëåéñêàÿ ýíöèêëîïåäèÿ
Àðõèòåêòóðíûé ñëîâàðü
Áèçíåñ ñëîâàðü
Áèîãðàôè÷åñêèé ñëîâàðü
Ñëîâàðü Äæèíñû
Ëîãè÷åñêèé ñëîâàðü
Ìåäèöèíñêèé ñëîâàðü
Ìîðñêîé ñëîâàðü
Ðåëèãèîçíûé ñëîâàðü
Ñåêñîëîãè÷åñêèé ñëîâàðü
Ñëîâàðü èìåí
Ñëîâàðü ìåð
Ñëîâàðü íóìèçìàòà
Ñëîâàðü ïî ïñèõîëîãèè
Ñëîâàðü ñèìâîëîâ
Ôèíàíñîâûé ñëîâàðü
Ýòíîãðàôè÷åñêèé ñëîâàðü
Áîëüøîé Ýíöèêëîïåäè÷åñêèé ñëîâàðü
Áîëüøîé áóõãàëòåðñêèé ñëîâàðü
Cëîâàðü-ñïðàâî÷íèê ïî Äðåâíåé Ãðåöèè, Ðèìó è ìèôîëîãèè
Àááðåâèàòóðû
Áèîãðàôè÷åñêèé ñëîâàðü Ôðàíöèè
Íîâåéøèé ôèëîñîôñêèé ñëîâàðü
Ñëîâàðü íàðêîòè÷åñêîãî ñëåíãà
Ñëîâàðü ðóññêèõ ëè÷íûõ èìåí
Ñëîâàðü ðóññêèõ ñèíîíèìîâ
Ñëîâàðü ðóññêèõ òåõíè÷åñêèõ ñîêðàùåíèé
Ñëîâàðü ñòðîèòåëÿ
Ñëîâàðü öåðêîâíûõ òåðìèíîâ
Ñëîâàðü ýïèòåòîâ
Ô.À. Áðîêãàóç, È.À. Åôðîí. Ýíöèêëîïåäè÷åñêèé ñëîâàðü
Ôèíàíñîâûé ýíöèêëîïåäè÷åñêèé ñëîâàðü
Ýíöèêëîïåäèÿ Êîëüåðà
Ýòèìîëîãè÷åñêèé ðóññêîÿçû÷íûé ñëîâàðü Ôàñìåðà
Ýòèìîëîãè÷åñêèé ñëîâàðü Êðûëîâà



Ãëàâíàÿ > Ýïîïðîñòåíîë (Epoprostenol)

Ýïîïðîñòåíîë (Epoprostenol)

Ýïîïðîñòåíîë (Epoprostenol)
ëåêàðñòâåííîå âåùåñòâî, â ñîñòàâ êîòîðîãî âõîäèò ïðîñòàãëàíäèí; ïðèìåíÿåòñÿ íåïîñðåäñòâåííî ïåðåä èëè âî âðåìÿ ïî÷å÷íîãî äèàëèçà äëÿ ïðåäîòâðàùåíèÿ îáðàçîâàíèÿ ñãóñòêîâ êðîâè â øóíòå. Íàçíà÷àåòñÿ âíóòðèâåííî.



Äîáðî ïîæàëîâàòü!
Áîëüøàÿ Áèáëèîòåêà
ïðèâåòñòâóåò Âàñ!

Ýïîïðîñòåíîë (Epoprostenol)



 

 Ïîèñê ïî ïîðòàëó:
 

© ÁÎËÜØÀß ÁÈÁËÈÎÒÅÊÀ 2008 ã.